{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T13:24:16Z","timestamp":1722777856020},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.intimp.2016.01.025","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T23:16:24Z","timestamp":1454714184000},"page":"55-62","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Loxoprofen sodium induces the production of complement C5a in human serum"],"prefix":"10.1016","volume":"33","author":[{"given":"Tomoaki","family":"Kumagai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Kodani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Haida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.01.025_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.iac.2014.09.009","article-title":"Optimizing the diagnosis of food allergy.","volume":"35","author":"Kattan","year":"2015","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.intimp.2016.01.025_bb0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/all.12333","article-title":"The diagnosis of food allergy: a systematic review and meta-analysis.","volume":"69","author":"Soares-Weiser","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2016.01.025_bb0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11882-012-0311-2","article-title":"Allergen component testing for food allergy: ready for prime time?","volume":"13","author":"Kattan","year":"2013","journal-title":"Curr. Allergy Asthma Rep"},{"key":"10.1016\/j.intimp.2016.01.025_bb0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000343880","article-title":"Strategies to query and display allergy-derived epitope data from the immune epitope database","volume":"160","author":"Vaughan","year":"2013","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome.","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.intimp.2016.01.025_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.","volume":"69","author":"Schwartz","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response.","volume":"136","author":"White","year":"2015","journal-title":"J. allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0040","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2217\/pgs.10.77","article-title":"Pharmacogenetics of drug hypersensitivity","volume":"11","author":"Phillips","year":"2010","journal-title":"Pharmacogenomics."},{"key":"10.1016\/j.intimp.2016.01.025_bb0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4168\/aair.2012.4.5.251","article-title":"Immunologic evaluation of drug allergy","volume":"4","author":"G\u00f3mez","year":"2012","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.intimp.2016.01.025_bb0050","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/cas.12538","article-title":"Carboplatin-induced severe hypersensitivity reaction: role of IgE-dependent basophil activation and Fc\u03b5RI.","volume":"105","author":"Iwamoto","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2016.01.025_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000441280","article-title":"Drug hypersensitivity: how drugs stimulate T cells via pharmacological interaction with immune receptors.","volume":"168","author":"Pichler","year":"2015","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0060","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1398-9995.2006.01039.x","article-title":"Flow-assisted allergy diagnosis: current applications and future perspectives.","volume":"61","author":"Ebo","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2016.01.025_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11882-012-0324-x","article-title":"Update on the performance and application of basophil activation tests.","volume":"13","author":"McGowan","year":"2013","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.intimp.2016.01.025_bb0070","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1586\/1744666X.2014.959498","article-title":"Basophil activation tests: time for a reconsideration.","volume":"10","author":"Uyttebroek","year":"2014","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cyto.b.20419","article-title":"Basophil activation test by flow cytometry: present and future applications in allergology.","volume":"74","author":"Ebo","year":"2008","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.intimp.2016.01.025_bb0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1067\/mai.2002.125257","article-title":"Recombinant allergens promote expression of CD203c on basophils in sensitized individuals.","volume":"110","author":"Hauswirth","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0091-6749(91)90094-5","article-title":"Monitoring human basophil activation via CD63 monoclonal antibody 435.","volume":"88","author":"Knol","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0090","first-page":"355","article-title":"Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis.","volume":"19","author":"De Weck","year":"2009","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0095","first-page":"39","article-title":"Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal anti-inflammatory drugs and its impact on pathogenesis.","volume":"20","author":"De Weck","year":"2010","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.aller.2010.12.011","article-title":"The values of nasal provocation test and basophil activation test in the different patterns of ASA\/NSAID hypersensitivity","volume":"40","author":"Wismol","year":"2012","journal-title":"Allergol. Immunopathol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0105","first-page":"91","article-title":"Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study.","volume":"19","author":"De Weck","year":"2009","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1710-1492-9-42","article-title":"Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions.","volume":"9","author":"Hagau","year":"2013","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0115","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/0006-2952(91)90242-W","article-title":"Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrug.","volume":"42","author":"Sugimoto","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1746.1995.tb01053.x","article-title":"Effects of loxoprofen sodium, a newly synthesized non-steroidal anti-inflammatory drug, and indomethacin on gastric mucosal haemodynamics in the human.","volume":"10","author":"Kawano","year":"1995","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0125","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1248\/bpb.33.398","article-title":"Low direct cytotoxicity of loxoprofen on gastric mucosal cells.","volume":"33","author":"Yamakawa","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2016.01.025_bb0130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1248\/yakushi.123.613","article-title":"The analysis of prescription frequency and the factors on adverse reactions of NSAIDs for post-operative pain in orthopedic patients.","volume":"123","author":"Ise","year":"2003","journal-title":"Yakugaku Zasshi."},{"key":"10.1016\/j.intimp.2016.01.025_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/s10165-012-0624-y","article-title":"Serum antibodies against the 70k polypeptides of the U1 ribonucleoprotein complex are associated with psychiatric syndromes in systemic lupus erythematosus: a retrospective study","volume":"23","author":"Katsumata","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1084\/jem.170.2.467","article-title":"Interleukin 3-dependent mediator release in basophils triggered by C5a.","volume":"170","author":"Kurimoto","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2016.01.025_bb0145","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.155.6.3152","article-title":"Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88\/C5aR expression on skin mast cells.","volume":"155","author":"F\u00fcreder","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2009.10.007","article-title":"Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.","volume":"128","author":"Ali","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2016.01.025_bb0155","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V100.2.517","article-title":"C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils.","volume":"100","author":"Wojta","year":"2002","journal-title":"Blood."},{"key":"10.1016\/j.intimp.2016.01.025_bb0160","doi-asserted-by":"crossref","first-page":"49403","DOI":"10.1074\/jbc.M209672200","article-title":"Identification of a potent and orally active non-peptide C5a receptor antagonist.","volume":"277","author":"Sumichika","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2016.01.025_bb0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000232428","article-title":"Effect of aspirin on the complement system in vitro.","volume":"61","author":"H\u00e4nsch","year":"1980","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1164\/rccm.200505-740OC","article-title":"Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma.","volume":"173","author":"Lee","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2016.01.025_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/IR:34:2:157","article-title":"The role of complement in danger sensing and transmission","volume":"34","author":"K\u00f6hl","year":"2006","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2016.01.025_bb0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2567.1999.00764.x","article-title":"Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.","volume":"97","author":"Zwirner","year":"1999","journal-title":"Immunol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0707332","article-title":"Function, structure and therapeutic potential of complement C5a receptors.","volume":"152","author":"Monk","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.01.025_bb0190","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ni.1926","article-title":"Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma.","volume":"11","author":"Lajoie","year":"2010","journal-title":"Nat. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T15:45:55Z","timestamp":1692200755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916300261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":38,"alternative-id":["S1567576916300261"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.01.025","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loxoprofen sodium induces the production of complement C5a in human serum","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}